Accelerating the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products.
At Rapid Micro Biosystems, we are dedicated to providing groundbreaking technology and products to support biomanufacturing companies in their mission to deliver the highest possible quality products for improved patient outcomes. Thanks to our unmatched expertise in science and technology, we are a trusted partner of healthcare product manufacturers around the world.
Rapid Micro Biosystems is headquartered and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands.
The trusted partner in quality control microbiology automation, enabling our customers to improve and save lives.
This vision has been realized with the development of the Growth Direct® System.
Our Growth Direct® System is a growth-based technology platform that fully automates the traditional compendial method of quality control (QC) microbiology testing in mission-critical applications such as environmental monitoring, water testing, and bioburden testing. It detects contamination more quickly, supports improved QC processes, and delivers compelling economic benefits.
By replacing slow, error-prone manual processes, the Growth Direct® System does much more than decrease error, ensure data integrity, and reduce the risk of costly contamination events. It also enables manufacturers to accelerate timelines, maximize capacity, and reduce operational risk and downtime. This results in better, more cost-effective pharmaceuticals, biologics, biotech products, medical devices, and personal care products.